Classifying health-related quality of life outcomes of total hip arthroplasty by Xu, Min et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Musculoskeletal Disorders
Open Access Research article
Classifying health-related quality of life outcomes of total hip 
arthroplasty
Min Xu*1, Donald S Garbuz2, Lisa Kuramoto3 and Boris Sobolev3
Address: 1Arthritis Research Centre of Canada, Vancouver, BC, Canada, 2Department of Orthopaedics, University of British Columbia, Vancouver, 
BC, Canada and 3Centre for Clinical Epidemiology & Evaluation, Vancouver, BC, Canada
Email: Min Xu* - mxu@arthritisresearch.ca; Donald S Garbuz - garbuz@shaw.ca; Lisa Kuramoto - lkuramot@vanhosp.bc.ca; 
Boris Sobolev - sobolev@interchange.ubc.ca
* Corresponding author    
Abstract
Background: Primary total hip arthroplasty (THA) is an effective treatment for hip osteoarthritis,
assessed by whatever distribution-based measures of responsiveness. Yet, the group level
evaluation has provided very little evidence contributes to our understanding of the large variation
of treatment outcome. The objective is to develop criteria that classify individual treatment health
related quality of life (HRQOL) outcome after primary THA, adjusted by preoperative scores.
Methods: We prospectively measured 147 patients' disease specific HRQOL on the date of
consultation and 12 months post operation by Western Ontario McMaster Universities
Osteoarthritis Index (WOMAC). Regression models were used to determine the "expected"
outcome for a certain individual baseline score. The ceiling effect of WOMAC measurement is
addressed by implementing a left-censoring method.
Results: The classification criteria are chosen to be the lower boundary of the 95% confidence
interval (CI) of the estimated median from the regression. The robustness of the classification
criteria was demonstrated using the Monte-Carlo simulation.
Conclusion: The classification criteria are robust and can be applied in general orthopaedic
research when the sample size is reasonable large (over 500).
Background
Statistical tests are frequently called upon to assess treat-
ments whose effect size is small or whose reduction of risk
is modest, as is often the case with emerging treatments.
But what of the evaluation of mature treatments whose
effect is known to be substantial?
Primary total hip arthroplasty (THA) is an effective treat-
ment for patients with severe hip osteoarthritis (OA). The
improvement is large by any of the measures of respon-
siveness commonly used in orthopaedic research [1-6].
Yet, there are large variations reported in treatment out-
come and very little good-quality evidence contributes to
our understanding of this variation [7,8]. The evidence is
limited mostly to patient- and implant-related factors [7].
The role of variations in service delivery practices and
other factors remains unclear. On the whole, patients' out-
come is good. Nevertheless, the development of classifica-
tion criteria to differentiate between overall good results is
necessary to achieve a better understanding of the vari-
ance and ultimately to reduce the number of relatively
poor performers.
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Because THA aims to improve physical function and
relieve pain, and because it is broadly successful in its
goal, health-related quality of life (HRQOL) is generally
acknowledged to be the primary outcome of interest
[9,10]. Assessment of HRQOL is typically made at the
group level, that is, by measures such as the t-test, effect
size (ES), and standard response mean (SRM), that are
characteristic of a group. However, using such methods
may not provide the best evidence to explain the associa-
tion between postoperative outcomes and risk factors [8].
In contrast, the measurement of individual changes is an
increasingly attractive method of quantifying HRQOL
outcomes because it has the potential to document objec-
tively the patient-perceived impact of treatment. Expecta-
tion and satisfaction are highly individualized; they
contribute significantly to self-assessed quality of life. But
these individualizing influences are lost in statistics such
as pre- and postoperative mean scores that only express a
group [11]. Raising the mean outcome is a worthwhile
objective, especially when the mean badly needs improve-
ment. When, as with effective treatments, the mean is not
an overriding concern, it is appropriate to turn our atten-
tion to individuals within the mean [12]. Even groups
whose mean change due to treatment is equivalent are
likely to contain individuals who did substantially better
and worse than others [13]. Developing statistical meth-
ods to assess these differences rather than the means
themselves is a natural accompaniment to the refinement
of treatments such as hip arthroplasty.
Two recent studies have found an association between
preoperative health status and postoperative outcomes
[14-16]. Fortin et al. examined the relationship between
preoperative functional status and postoperative out-
comes in a prospective cohort study using the Western
Ontario McMaster Universities Osteoarthritis Index
(WOMAC) and Short Form 36 (SF-36). They found that
poorer preoperative function was the strongest predictor
of pain and functional outcomes at 6 and 24 months after
THA [15,16]. The authors concluded that surgery per-
formed later in the natural history of functional decline
results in worse postoperative functional status. They also
noted that function and pain in patients with lower pre-
operative function did not improve after the operation to
the level achieved by those with higher preoperative
scores [15,16]. Thus, measures of postoperative HRQOL
outcome need to be adjusted by preoperative functional
status.
Methods
The objective of this study is to develop a tool for classify-
ing the HRQOL outcome of THA based on the individ-
ual's preoperative HRQOL score. The development of the
tool and the results of a simulation study are presented in
the methods section. We describe the design of a case
study evaluating the postoperative outcome for THA. In
the development of the instrument section, a left-cen-
sored linear regression model is employed as a means of
understanding and communicating the relationship
between baseline and expected outcome. An expected
postoperative HRQOL score for each individual preopera-
tive score is estimated using this left-censored linear
regression model. By using the expected HRQOL out-
come, we identify patients whose benefit from THA is
"better than expected." The performance of these classifi-
cation criteria is evaluated in difference sample sizes by
simulation. In the development of these classification cri-
teria we adjust the postoperative outcome by its preoper-
ative score. The result of this simulation study shows that
these classification criteria are robust.
Study population
Data from a prospective cohort study were used for a case
study. This study included 201 patients registered on the
wait list for THA between March, 2001 and May, 2003
with 147 patients completed follow-up ending in March,
2004. This study was conducted at the Vancouver Hospi-
tal & Health Sciences Centre. Ethical approval was issued
by the University of British Columbia Clinical Ethics
Review Board. Patients presenting during this period at
the Division of Reconstructive Orthopedics at Vancouver
Hospital (VH) with a diagnosis of osteoarthritis (OA) and
requiring primary THA are included in the study. OA is
defined by the American College of Rheumatology's
(ACR) clinical classification criteria for OA of the hip [17].
Patients were excluded for the following reasons: previous
THA to the index joint; inflammatory arthritis; bilateral
THA performed simultaneously; inability to respond to a
The distribution of baseline WOMAC functional scores Figure 1
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questionnaire in English; and urgent surgery performed
within 28 days after the decision for THA.
Every patient requiring hip arthroplasty was requested to
complete the WOMAC questionnaire on the date of con-
sultation. The questionnaire is self-administered. Medical
office assistants handed each patient a WOMAC question-
naire once the decision was reached to enter the wait list.
To assess postoperative outcomes, WOMAC question-
naires were mailed at 12 months following surgery.
WOMAC is recommended for OA-specific outcomes
[18,19]. It contains dimensions for pain (5 items), stiff-
ness (2 items), and function (17 items). Dimensions are
equally weighted and reported as sums, where the higher
number indicates a greater burden of OA. At present it is
the most frequently used measure of pain and self-
reported disability among arthroplasty patients [10]. The
WOMAC questionnaire has 24 questions, each question is
given a Likert scale response from 0 (best health state) to
4 (worst health state). The WOMAC score for each sub-
scale is calculated as the sum of the scores of each
question included in the subscale. The range of each
subscale is as follows: function: 0–68; pain: 0–20; stiff-
ness: 0–8.
Patients' names and provincial health numbers were used
to obtain age and gender through the medical office
administrative database. Co-morbidity information was
obtained through medical chart review using the Charnley
classification, which stratifies patients by the presence of
OA in one or both hips, or a co-morbid condition that
impairs walking. This scale allows a meaningful compari-
son between groups [20]. The Charnley classes we used
are:
A: Single hip with osteoarthritis
B1: Bilateral hips with arthritis
B2: Previous THA on the contra-lateral hip
C: Multiple joints affected with arthritis or a chronic disease
that affects HRQOL (specifically walking)
Statistical analysis
Log-linear regression model
In the following, we aim at building a linear model to
explore the relationship between follow-up score and
baseline score. Since the distribution is skewed (Fig. 1 &
Fig. 2), one cannot use the follow-up score in a linear
regression analysis as an outcome variable. We found that
the logarithms of the follow-up WOMAC functional
scores follow a symmetrical distribution (Fig. 3). There-
fore we build a log-linear regression as following:
log(Follow-up) = α+β*Baseline+σ*ε,
where Follow-up is the follow-up WOMAC score and Base-
line is the baseline WOMAC score. The error term ε fol-
lows a normal distribution with a mean of 0 and a
standard deviation of 1, and σ is a fixed constant that
changes the variability of the expected value.
However the observed follow-up data has some WOMAC
function score equal to zero and the logarithm of 0 is infi-
nite. So we can not censor the postoperative score at 0.
The distribution of follow-up WOMAC function scores Figure 2
The distribution of follow-up WOMAC function scores.
The distribution of the logarithms of follow-up WOMAC  functional scores Figure 3
The distribution of the logarithms of follow-up WOMAC 
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Moreover, the WOMAC function 0 is corresponding to
complete freedom from joint symptoms. It is unlikely that
patients before and after THA would have no detectable
impairment in their hip. Therefore, as a measurement
tool, the WOMAC questionnaire is limited in providing
HRQOL information at the extreme low end of the scale
(score of 0). Since a true score is unknown when the score
is between 0 and 1, we regard measurements below 1 as
left-censored observations. In our model, we chose 0.9 to
be the censoring point so that 1 was preserved in the
model and 0 was censored. We transformed the observed
follow-up score as follows:
Follow-up = 0.9, if Follow-up <= 0.9;
Follow-up = Follow-up, if Follow-up > 0.9,
The Tobit regression model is a well known instrument
for measuring left-censored variables in economic
research [21]. In order to incorporate the left-censored
observations in the regression analysis, we built a Tobit
model to incorporate the left-censored observations in the
regression analysis. The maximum likelihood method
was used to estimate the probabilities of log(Follow-up)
given the baseline WOMAC score. The regression analysis
was conducted using the SAS 8.1 PROC LIFEREG
procedure.
Instrument for classifying function outcomes
Through this regression analysis, an expected postopera-
tive outcome for each baseline WOMAC functional score
was obtained. Due to the skewed distribution of follow-
up scores, we used the median of the follow-up score
instead of the mean as the classification criteria. The mean
of the predicted logarithm of follow-up scores was esti-
mated through the model, and the median of estimated
follow-up scores is exp (mean of log(Follow-up)) accord-
ing to the mathematical transformation.
Since the model is derived from a rather small size sam-
ple, the variation of the estimated median of the follow-
up scores should be taken into consideration. Using the
lower 95% confidence interval of the median as a cutoff
point associated with the baseline score, the study
patients were divided into two groups. Group I: Patients
below the line were considered to have achieved a "better than
expected" outcome. Group II: Patients above the line were con-
sidered to have achieved a "not better than expected" outcome.
Assessment of the classification instrument
We implemented the Monte-Carlo simulation method to
investigate the robustness of our classification criteria.
Our intention was to assess the robustness across baseline
scores and for different sample sizes. We generated ran-
dom postoperative WOMAC functional scores assuming a
systematic relationship between the baseline scores and
postoperative WOMAC functional scores and adding a
random component. The systematic relationship and the
parameters for the random component were specified
from the Tobit model estimates in our case study. In each
data set, postoperative scores were generated for baseline
WOMAC functional scores fixed at 10, 17, 34, 51, and 68.
We chose 10 since it is the lowest baseline score that is eli-
gible for surgery and available in the case study. The func-
tional subscale contains 17 questions; each question has a
response on Likert scale from 0 to 4. Therefore, we chose
the folds of 17 as the baseline levels for simulation. The
postoperative score was left-censored at 0.9. We looked at
sample sizes increasing from 100 to 500 in increments of
100. For each sample size, we generated 1000 data sets.
Then, for each data set, the regression model was fit and
the median postoperative score and the cutoff points (ie.
the lower bound of the 95% CI for the median score) were
estimated at each baseline score.
We also tested the model using same method with differ-
ent censoring points (0.9, 2, 3, 4, and 5) while the sample
size was fixed at 500. For each censoring point, we gener-
ated 1000 datasets and the cutoff points were estimated
for each data set.
Results
Study population
This study included 201 patients, among which there are
147 patients completed follow-up ending in March, 2004.
The average age is 64.8 years and there are 83 females
(56%) and 66 males (44%) in the study. Seventy-two
patients (50%) have only one joint involved with OA; 34
patients have bilateral disease. Of these 34 patients, there
are 18 with contra-lateral hip replacement prior to the
index surgery and 16 patients with moderate to severe OA
in the contra-lateral hip. Thirty-nine patients (27%) have
multiple joints involved with OA or have a chronic sys-
tematic disease. When compare the component of age,
gender and disease statues, there are no statistical differ-
ences of between the 147 patients and 54 patients who
did not complete follow-up. In the following analysis, all
the results are based on the 147 patients who completed
follow-up. We found that the distribution of baseline
WOMAC functional scores (scale 0–68) follows a
Table 1: Parameter estimation for the log-linear regression
Parameters Estimates 95% CI
Intercept 0.98 0.29–1.67
Coefficient 0.03 0.01–0.05
Scale 1.30 1.14–1.48BMC Musculoskeletal Disorders 2005, 6:48 http://www.biomedcentral.com/1471-2474/6/48
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symmetrical distribution and its' mean and standard devi-
ation (SD) are 39 and 13 respectively (Fig. 1). Its mini-
mum is 10 points and median is 41 points. While at the
end of the follow-up, the distribution of WOMAC func-
tional scores (scale 0–68) shows a truncated distribution
because the follow-up outcome is nearly as good as a full
recovery or normal function; that is, the follow-up out-
comes have a limit as a score of 0 (best function). The
mean follow-up WOMAC functional score is 14 (SD =
14). Its minimum is 0 points and median is 8.5 points.
Since the distribution is skewed, one cannot use the fol-
low-up score in a linear regression analysis as an outcome
variable.
Log-linear regression model
Table 1 shows the parameter estimates obtained through
this regression analysis. For the sample population, the
estimate of the expected value of the lognormal distribu-
tion is given by:
Log(Follow-up) = 0.98+0.03*Baseline.
Based on the model, the baseline WOMAC functional
score is a significant predictor of the follow-up WOMAC
functional score (p = 0.0005). Increasing the baseline
score by 10 points raises the estimated postoperative score
by approximately 35%. The estimated median score line
and its 95% confidence interval are shown in Fig. 4.
95% confidence interval for the median of expected function outcomes Figure 4
95% confidence interval for the median of expected function outcomes.BMC Musculoskeletal Disorders 2005, 6:48 http://www.biomedcentral.com/1471-2474/6/48
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Age, gender, co-morbidity, and waiting time were also
tested as covariates in the log-linear regression model.
None of these variables were significant predictors of the
follow-up WOMAC functional score and there was no dif-
ference in the regression coefficient for baseline WOMAC
functional scores with or without these covariates. A
goodness of fit test showed that the Tobit model is well fit-
ted. In the model, the outliers are detected by the studen-
tized residual; those observation having an absolute
studentized residual over 3.5 were removed.
Instrument for classifying function outcomes
The simulation results are summarized in Fig. 5, 6, 7, 8
and Table 2. Fig. 5 summarizes that the median estima-
tion is very consistent despite the increase in sample size.
Table 2 represents the same information as Fig. 5, but pro-
vides the actual values for classification criteria that can be
used as a reference table for future researchers.
Fig. 6 summarizes the results of classification criteria in
simulated data sets with different sample size. While the
sample size increases, the mean of the cutoff points
approaches the mean of the median estimation. That is,
when the sample size is reasonable large (n = 500), the cut
off points are almost equivalent to the estimated median.
Fig. 7 summarizes the coefficient of variation (CV) for the
distribution of classification criteria, in simulated data
sets with different sample size. The lower the CV is, the
higher the precision of the estimation is. This plot shows
two trends. First, the CV is lowest at the median baseline
level and increases toward the extreme values in both
directions, as expected. For example, in a sample of 100
patients, the CV of the estimated cutoff point is 12.5% at
baseline 34, 20.2% at baseline 10 and 22.8% at baseline
68. That is, the precision of this estimation is the highest
when the baseline is around 34 and reduced toward both
extremes. Second, we also found that the CV decreases
with the sample size. For example, at baseline 34, the CV
is 12.5% for 100 scores and 5.3% for 500 scores. This
indicates that the precision of the estimation increases
with a larger sample size.
Fig. 8 summarizes the CV for the distribution of classifica-
tion criteria, in simulated data sets with different
censoring points. While sample sizes being fixed at 500,
we found that the CV increases with higher censoring
level. This indicates that the precision of the estimation
increases with a lower censoring point. Therefore censor-
ing postoperative scores at 0.9 is preferred over censoring
at a higher level.
Discussion
In the past decade the orthopaedic community has shifted
toward the inclusion of patient-based measures of out-
come assessments [22]. It was typical of earlier orthopedic
practice that the patient's perspective received less atten-
tion than did clinician's measures of disease and
impairment [23,24]. Clinicians used complication rates,
mortality, most frequently revision rates and clinical judg-
ment to assess the degree of improvement [25]. Since
THA, in most cases, aims explicitly to improve HRQOL,
using HRQOL measures as endpoint in orthopaedic
research on evaluation of treatment outcome is now seen
as a necessity to fully understand the effects of this inter-
vention [26].
THA is an effective treatment by any of the distribution-
based measures of responsiveness [6]. Yet, there are large
variations reported in treatment outcome. Why some
patients do better than others post-operation? Group level
perspective on evaluation of treatment outcome has pro-
vided very little evidence contributes to our understand-
ing of this question.
Most reports of the HRQOL outcome of THA use distribu-
tion-based approaches that test the significance of the
change due to treatment [22]. However, distribution-
based approaches are based on the statistical characteris-
tics of the sample. For example, paired t-statistics are
frequently used to estimate the statistical significance of
Table 2: Average of the classification criteria
Average of the classification criteria
Baseline N = 100 N = 200 N = 300 N = 400 N = 500
10 3.5 3.5 3.4 3.4 3.5
17 4.2 4.2 4.2 4.2 4.2
34 6.8 6.8 6.8 6.8 6.8
51 11.1 11.1 11 11 11
68 18.2 18.1 17.9 17.8 17.8BMC Musculoskeletal Disorders 2005, 6:48 http://www.biomedcentral.com/1471-2474/6/48
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the change [27]. The problem with using the t-test as a
measure of change is that it focuses exclusively on the
significance which will inevitably increase with sample
size [28]. A different problem exists in determining the
minimal clinically significant difference for THA. In
clinical drug trials, a 9.3 point change in WOMAC func-
tional score was accepted as a minimally significant
improvement in arthritis symptoms [29]. But the 9.3-
point change is too small to be applied to the outcomes of
THA which typically show a 60–100% improvement over
baseline [15,16]. The expected change in WOMAC func-
tional scores after THA is four times larger than the mini-
mal clinically important difference derived from drug
trials in OA. Effect size (ES) and standard response mean
(SRM) are also common measures for responsiveness at
the group level. Cohen's criteria can be used to classify
responsiveness as mild, moderate, and large [30]. But
these statistics may be influenced by the heterogeneity of
the sample. Moreover, Cohen's magnitude of effect does
not suit the nature of orthopaedic surgery. An effect size
larger than 0.8 is considered a "large effect". However, by
that criterion, the majority of patients in our case study
would be considered to have experienced a "large effect"
both by ES and SRM statistics. Such criteria are inadequate
for documenting the positive impacts of treatment. Char-
acteristics of the baseline distribution will strongly influ-
ence the effect size, while variability of the change in the
sample may influence the standard response mean.
We developed a method to classify the HRQOL outcome
on an individual level. Group distributions can have a
negligible mean difference with large variance. Therefore,
the large differences that are important to individuals are
not measured by group level, whereas the individual level
takes them into account. This makes the individual per-
spective important for clinical treatment decisions
[13,28]. We have shown that improvement after hip
arthroplasty is not as big when the patients have a better
preoperative score; therefore, postoperative outcomes are
not evaluated at the group level but rather at each
individual baseline level, so that for each individual
patient an expected outcome can be generated.
We addressed the ceiling effect of the WOMAC instrument
in the measurement of postoperative outcome of THA, as
10% of patients in our case study recorded a postoperative
WOMAC score of 0. A ceiling effect occurs when a patient
can improve only minimally or not at all. In the presence
of a ceiling effect, the paper by Austin et al. suggests that
the coefficient estimates from the left-censored regression
model are better than the estimates from a least square
regression [31]. We address the ceiling effect by imple-
menting a linear regression of log-transformed WOMAC
function score while treating postoperative scores as left-
censored at 0.9. The regression model represents the rela-
tionship between baseline and postoperative outcome.
The estimated median of postoperative scores was chosen
to distinguish between those who are able to benefit fully
from treatment and those who are not. Due to the small
sample size, the classification criteria in this case study is
the lower boundary of the 95% confidence interval (CI) of
The average of the median estimates from simulation Figure 5
The average of the median estimates from simulation.
Average of the estimated median and classification criteria Figure 6
Average of the estimated median and classification criteria.BMC Musculoskeletal Disorders 2005, 6:48 http://www.biomedcentral.com/1471-2474/6/48
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the estimated median. Our study results agrees with the
previous literature in that postoperative HRQOL scores
were found to be strongly associated with their baseline
values. We evaluated the changes in the WOMAC
dimensions of pain, stiffness, and function from pre- to
post operation. The effects of age, gender, and co-morbid-
ity on follow-up WOMAC scores were not statistically sig-
nificant, so these are excluded from the regression model.
The performance of the classification criteria was demon-
strated using the Monte-Carlo simulation. The variation
of the classification criteria will decrease with increasing
sample size; likewise, the classification criteria become
closer to the estimated median with increasing sample
size. Thus, with a small sample set, researchers could use
the lower boundary of 95% CI of the estimated median as
the classification criteria. When there is a reasonable
larger sample (bigger than 500), one could use the esti-
mated median itself as the classification criteria.
The limitation of this research is that the estimated classi-
fication criteria were not validated in a different clinical
setting. Instead, they were evaluated through simulation.
Therefore, we are recommending that clinicians use only
the methods rather than the actual values of the classifica-
tion criteria until further research is done in this area.
Conclusion
The contribution of this paper is two-fold. First, the crite-
ria for classify individual treatment outcome adjusted by
baseline score was proposed. The development of these
classification criteria also addresses the ceiling effect of the
HRQOL measurement. Second, the performance of the
classification criteria was found to be more precise with a
reasonable larger sample size (n > 500). Vancouver Hos-
pital (VH) is a tertiary referral centre and teaching hospital
for the University of British Columbia (UBC). The demo-
graphics of arthroplasty patients, however, are not differ-
ent from elsewhere. The study result is expected to be
generalizable to a similar clinical setting.
This paper provides intuitive criteria for classifying
HRQOL outcomes based on individual scores before sur-
gery. The result of this method is an individual outcome
which can serve as a standard advice for patient coun-
seling based on HRQOL status at consultation. It gives
orthopaedic researchers a means of defining "success" of
effective surgery. In the future, we will evaluate this
method in different populations and with other HRQOL
instruments such as Oxford Hip Score and the Short Form
12 questionnaire.
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